rituximab,epcoritamab,lenalidomide
abbvie,genmab
[' lena', 'epcoritamab', 'lenalidomide', 'ritux', 'lymsm', 'lymphoma', 'follicular']
#ash22 continues! will be sharing data from a phase 1/2 clinical trial of subcutaneous epcoritamab with rituximab + lenalidomide, which offers promising results for people with r/r follicular lymphoma. 5:00 p.m. today. #lymsm learn more: 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept head @debschrag